Search

admin@aosuotrade.com

86-0311-68015506 ; 86-15032065295

86-0311-68015506 ; 86-15032065295

Shijiazhuang Aosuo International Trade Co., Ltd.       冀ICP备19004403号-1        Powered by www.300.cn

Shijiazhuang Aosuo International Trade Co., Ltd.

>
>
Orthopedic implant industry that cannot be ignored

News details

Orthopedic implant industry that cannot be ignored

Page view
[Abstract]:
The common treatment methods of orthopedic diseases include conventional drug treatment, physical treatment, surgery and medical device treatment, etc. orthopedic medical devices are one of the largest sub industries in the medical device industry, and orthopedic implants are the most important category of orthopedic devices, which are usually surgery or part or all of the implanted human body after surgery to replace, support, locate or repair bones, customs, etc Devices and materials for tissues such as arthrodes and cartilage.

The common treatment methods of orthopedic diseases include conventional drug treatment, physical treatment, surgery and medical device treatment, etc. orthopedic medical devices are one of the largest sub industries in the medical device industry, and orthopedic implants are the most important category of orthopedic devices, which are usually surgery or part or all of the implanted human body after surgery to replace, support, locate or repair bones, customs, etc Devices and materials for tissues such as arthrodes and cartilage.

With the rapid expansion of medical device industry, driven by the increasing proportion of social aging, the increase of national health care investment, the improvement of medical insurance coverage and the enhancement of residents' ability to pay, orthopedic implants, as a "medical high value consumables" with high price and one-time use, have considerable market capacity and industry growth.

The development of orthopedic implant

The orthopaedic specialty in China experienced a difficult development process before the 1980s, but laid a certain foundation for the development of orthopaedic equipment industry. Orthopedic implant has evolved from surgical instruments, and its early development is relatively slow. It has a large gap with the international advanced level in research and development, production technology and marketing.

With the rapid improvement of national economic strength and scientific research strength, especially after entering the 21st century, multinational enterprises have entered the Chinese market, which has driven the rapid development of domestic enterprises. In the continuous learning and competition, domestic orthopedic devices have made great progress in all aspects, and gradually began to break the pattern of foreign monopoly.

Orthopedic implant related industrial policies

In recent years, in order to encourage domestic medical devices to accelerate innovation, the state has given greater support from the policy level. The State Council and the competent government departments have issued a series of industrial policies to revitalize the medical device industry.

Main classification and market situation of orthopaedic implants

Orthopedic implants can be divided into trauma, spine, joint and others. The market share of the first three can account for more than 80% of orthopedic devices.

Trauma products are mainly used for reduction, fixation and stability of various fracture injuries, mainly including plates (locking plates and ordinary plates), intramedullary nails, screws, bone needles and other fixation devices. According to the different parts of use, they can be divided into internal fixation and external fixation. In practical application, the material used for internal fixation accounts for about 95%.

Joint products usually include some artificial joint prostheses, which are used to replace or reconstruct the damaged or peripheral bone defects caused by arthritis, hyperosteogeny, rheumatism, bone tumor or excessive sports injury. At the same time, conservative treatment is not effective for the joints, so that the patients can recover normal joint function and movement ability, and reduce the joint pain caused by pathological changes. Because this kind of equipment needs to be implanted in the body for a long time, the product needs to simulate the movement state and function of human physiological joints as much as possible, and has higher requirements on the stability and biocompatibility of the implanted materials. Among them, hip joint and knee joint account for more than half of all products.

Spine is one of the most important bone systems of human body, which is mainly composed of small bone, intervertebral disc, ligament, muscle and joint of vertebrae. Common spine diseases include various dosage forms, tumors and fractures, degeneration, dislocation of vertebrae and intervertebral disc and so on. The main causes can be osteoporosis, osteoarthritis and other pathological reasons, or chronic injury caused by bad living habits or It was accidental. In addition to drug therapy and physical therapy and other conservative treatment methods, the treatment of spine diseases also includes surgical internal fixation and domestic leading minimally invasive vertebroplasty interventional therapy.

In addition, orthopedic implants also include some filling materials for filling or repairing bone defects, mainly including bone cement, bioceramics, hydroxyapatite, Bioglass, allogeneic bone, allogeneic bone, etc.

According to a new report from allied market research, the global orthopedic implant market reached US $47.261 billion in 2016 and is expected to reach US $74.796 billion by 2023. During the forecast period of 2017-2023, the annual compound growth rate is 6.8%.

According to the data, the number of surgeries for intra-articular implants in China has increased from about 1.7 million in 2012 to 2.9 million in 2016, with a compound annual growth rate of 13.8%. It is expected that the number will increase to 4.7 million in 2021, with a compound annual growth rate of 10.2% from 2016 to 2021.

In terms of revenue, China's total intra-articular implant market is expected to grow to 20.3 billion yuan in 2021, with a compound annual growth rate of 10.6% from 2016 to 2021. The joint and spine markets are expected to grow to 7.8 billion yuan and 5.1 billion yuan respectively, with a compound annual growth rate of 13.7% and 9.5% from 2016 to 2021.